Begin main content

Screening for Vancomycin-Resistant Enterococci in Patients Admitted to Hospital: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: July 17, 2019
Project Number: RB1362-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of selective screening versus universal screening or no screening of vancomycin-resistant enterococci in patients admitted to hospital?
  2. What is the cost-effectiveness of selective screening versus universal screening or no screening of vancomycin-resistant enterococci in patients admitted to hospital?
  3. What are the evidence-based guidelines regarding screening of vancomycin-resistant enterococci in patients admitted to hospital?

Key Message

One health technology assessment, two non-randomized studies, and one economic evaluation were identified regarding the selective screening versus universal screening or no screening of vancomycin-resistant enterococci in patients admitted to hospital. In addition, two evidence-based guidelines were identified regarding the screening of vancomycin-resistant enterococci in patients admitted to hospital. No systematic reviews, meta-analyses, or randomized controlled trials were identified.